Marvel Biosciences Corp's total assets for Q2 2026 were C$319.62K, a decrease of -2.17% from the previous quarter. TSE:MRVL total liabilities were C$4.18M for the fiscal quarter, a -3.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.